VYLOY 20 mg/mL (Zolbetuximab INJECTION, POWDER, FOR SUSPENSION) 20 mg/mL

Vyloy 20 mg/mL is an injectable powder for suspension used in intravenous therapy. This medication, containing zolbetuximab, is designed for specific therapeutic applications. Learn more about its uses and effects.

Strength

20 mg/mL

Pack Size

1 VIAL in 1 BOX (0469-3425-10) / 5 mL in 1 VIAL

Manufacturer / TM Owner

Astellas Pharma US, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vyloy 20 mg/mL is primarily used in the treatment of certain types of cancer. The active ingredient, zolbetuximab, targets specific cells to help manage the condition. Patients often wonder, 'What is Vyloy used for?' and it is generally prescribed for targeted therapy in oncology.

Side Effects

Common effects of Vyloy 20 mg/mL may include reactions at the injection site, fatigue, and gastrointestinal issues. Patients should monitor their body's response and consult their healthcare provider if they experience severe or persistent effects.

Precautions & Warnings

Vyloy should be handled with care, following the instructions provided by a healthcare professional. It is important to store the medication properly and use it as directed. Patients with certain medical conditions may need to exercise additional caution.

Avoid Interactions

Vyloy may interact with other medications, including those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Vyloy.

Frequently Asked Questions

Vyloy is used in the treatment of certain types of cancer, targeting specific cells for therapy.

Vyloy is administered intravenously as a powder for suspension, prepared and used under medical supervision.

Common effects may include injection site reactions, fatigue, and gastrointestinal issues.

Vyloy may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Vyloy should be stored according to the instructions provided, typically in a cool, dry place away from direct sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.